Tenaya Therapeutics Inc (TNYA)
4.68
+0.06
(+1.30%)
USD |
NASDAQ |
May 03, 16:00
4.68
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Price to Book Value: 2.636 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.636 |
| May 02, 2024 | 2.602 |
| May 01, 2024 | 2.636 |
| April 30, 2024 | 2.557 |
| April 29, 2024 | 2.557 |
| April 26, 2024 | 2.427 |
| April 25, 2024 | 2.376 |
| April 24, 2024 | 2.467 |
| April 23, 2024 | 2.506 |
| April 22, 2024 | 2.495 |
| April 19, 2024 | 2.433 |
| April 18, 2024 | 2.416 |
| April 17, 2024 | 2.422 |
| April 16, 2024 | 2.512 |
| April 15, 2024 | 2.517 |
| April 12, 2024 | 2.512 |
| April 11, 2024 | 2.641 |
| April 10, 2024 | 2.523 |
| April 09, 2024 | 2.551 |
| April 08, 2024 | 2.607 |
| April 05, 2024 | 2.641 |
| April 04, 2024 | 2.579 |
| April 03, 2024 | 2.698 |
| April 02, 2024 | 2.585 |
| April 01, 2024 | 2.810 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.945 |
| March 27, 2024 | 2.906 |
| March 26, 2024 | 2.72 |
| March 25, 2024 | 2.737 |
| March 22, 2024 | 2.658 |
| March 21, 2024 | 2.692 |
| March 20, 2024 | 2.759 |
| March 19, 2024 | 2.551 |
| March 18, 2024 | 2.714 |
| March 15, 2024 | 2.802 |
| March 14, 2024 | 2.686 |
| March 13, 2024 | 3.047 |
| March 12, 2024 | 3.126 |
| March 11, 2024 | 3.109 |
| March 08, 2024 | 3.604 |
| March 07, 2024 | 3.548 |
| March 06, 2024 | 3.717 |
| March 05, 2024 | 3.829 |
| March 04, 2024 | 3.722 |
| March 01, 2024 | 3.756 |
| February 29, 2024 | 3.286 |
| February 28, 2024 | 3.258 |
| February 27, 2024 | 3.225 |
| February 26, 2024 | 3.142 |
| February 23, 2024 | 2.883 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3836
Minimum
Nov 08 2022
4.021
Maximum
Nov 11 2021
1.553
Average
1.396
Median
Price to Book Value Benchmarks
| Adverum Biotechnologies Inc | 2.594 |
| Solid Biosciences Inc | 3.023 |
| Dyne Therapeutics Inc | 4.767 |
| Sana Biotechnology Inc | 8.005 |
| Prime Medicine Inc | 5.042 |
Price to Book Value Related Metrics
| Price | 4.68 |
| Earnings Yield | -35.68% |
| Market Cap | 367.46M |